Author Aethlon Medical Australia

Aethlon Medical Australia PTY LTD, a subsidiary of Aethlon Medical, is dedicated to advancing innovative therapies for cancer. Our mission is clear: to improve patient outcomes through scientific research and clinical research. At the core of our efforts is the Hemopurifier®, an investigational medical device designed to remove harmful extracellular vesicles (EVs) and viruses from the bloodstream. These particles released by cells can contribute to the spread of cancers, making them a key target to enhance the effectiveness of existing therapies. By filtering out these harmful elements, the Hemopurifier® may help improve the body’s immune system to attack the cancer.